MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine (Q39210882)
Jump to navigation
Jump to search
scientific article published on 14 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine |
scientific article published on 14 January 2013 |
Statements
1 reference
MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine (English)
1 reference
Y Xiang
1 reference
N Ma
1 reference
D Wang
1 reference
Y Zhang
1 reference
J Zhou
1 reference
G Wu
1 reference
R Zhao
1 reference
H Huang
1 reference
X Wang
1 reference
Y Qiao
1 reference
F Li
1 reference
D Han
1 reference
L Wang
1 reference
G Zhang
1 reference
X Gao
1 reference
14 January 2013
1 reference
1 reference
33
1 reference
3
1 reference
378-386
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference